A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease

Alzheimer's and Dementia

Volumn 10, Issue 6, 2014, Pages 646-655

  Barnes, Deborah E ^a,b,c   Cenzer, Irena S ^a,c   Yaffe, Kristine ^a,b,c   Ritchie, Christine S ^a,c,d   Lee, Sei J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Jewish Home of San Francisco   (United States)

Author keywords

Aged; Alzheimer's disease; Disease progression; Human; Magnetic resonance imaging; Mild cognitive impairment; Neuropsychological tests; Prognostic modeling; Risk factors

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BOSTON NAMING TEST; CLINICAL DEMENTIA RATING; CLOCK DRAWING TEST; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIGIT SPAN FORWARD AND BACKWARD TEST; DIGIT SYMBOL SUBSTITUTION TEST; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT QUESTIONNAIRE; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MODIFIED HACHINSKI ISCHEMIA SCORE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; REY AUDITORY VERBAL LEARNING TEST; WECHSLER MEMORY SCALE; BRAIN; COMPLICATION; DISEASE COURSE; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; REPRODUCIBILITY; VERY ELDERLY;

APOLIPOPROTEIN E4;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES;

EID: 84927178222     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.12.014     Document Type: Article

References (50)

1. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308
2. R.C. Petersen, R.O. Roberts, D.S. Knopman, B.F. Boeve, Y.E. Geda, and R.J. Ivnik Mild cognitive impairment: ten years later Arch Neurol 66 2009 1447 1455
3. K. Yaffe, R.C. Petersen, K. Lindquist, J. Kramer, and B. Miller Subtype of mild cognitive impairment and progression to dementia and death Dementia Geriatr Cogn Disord 22 2006 312 319
4. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
5. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
6. D.A. Bennett, R.S. Wilson, J.A. Schneider, D.A. Evans, L.A. Beckett, and N.T. Aggarwal Natural history of mild cognitive impairment in older persons Neurology 59 2002 198 205
7. H. Brodaty, M. Heffernan, N.A. Kochan, B. Draper, J.N. Trollor, and S. Reppermund Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study Alzheimers Dement 9 2013 310 317
8. M. Ganguli, B.E. Snitz, J.A. Saxton, C.C. Chang, C.W. Lee, and J. Vander Bilt Outcomes of mild cognitive impairment by definition: a population study Arch Neurol 68 2011 761 767
9. A. Forsberg, H. Engler, O. Almkvist, G. Blomquist, G. Hagman, and A. Wall PET imaging of amyloid deposition in patients with mild cognitive impairment Neurobiol Aging 29 2008 1456 1465
10. V.L. Villemagne, K.E. Pike, G. Chetelat, K.A. Ellis, R.S. Mulligan, and P. Bourgeat Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease Ann Neurol 69 2011 181 192
11. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, and R.C. Petersen Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
12. G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, F. Eustache, and J.C. Baron Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60 2003 1374 1377
13. A. Drzezga, T. Grimmer, M. Riemenschneider, N. Lautenschlager, J. Siebner, and P. Alexopoulus Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET J Nucl Med 46 2005 1625 1632
14. S.L. Risacher, A.J. Saykin, J.D. West, L. Shen, H.A. Firpi, and B.C. McDonald Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort Curr Alzheimer Res 6 2009 347 361
15. J.L. Whitwell, S.A. Przybelski, S.D. Weigand, D.S. Knopman, B.F. Boeve, and R.C. Petersen 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease Brain 130 2007 1777 1786
16. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
17. D.E. Barnes, K.E. Covinsky, R.A. Whitmer, L.H. Kuller, O.L. Lopez, and K. Yaffe Predicting risk of dementia in older adults: the late-life dementia risk index Neurology 73 2009 173 179
18. W.B. Kannel, D. McGee, and T. Gordon A general cardiovascular risk profile: the Framingham Study Am J Cardiol 38 1976 46 51
19. S.J. Lee, K. Lindquist, M.R. Segal, and K.E. Covinsky Development and validation of a prognostic index for 4-year mortality in older adults JAMA 295 2006 801 808
20. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, and R.C. Green The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 8 Suppl. 2012 S1 68
21. W.G. Rosen, R.D. Terry, P.A. Fuld, R. Katzman, and A. Peck Pathological verification of ischemic score in differentiation of dementias Ann Neurol 7 1980 486 488
22. J.I. Sheikh, and J.A. Yesavage Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In: Clinical gerontology: a guide to assessment and intervention 1986 Haworth Press New York 165 173
23. D. Wechsler Wechsler Memory Scale - revised 1987 Psychological Corporation San Antonio, TX
24. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
25. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
26. E. Grober, and M. Sliwinski Development and validation of a model for estimating premorbid verbal intelligence in the elderly J Clin Exp Neuropsychol 13 1991 933 949
27. R.I. Pfeffer, T.T. Kurosaki, C.H. Harrah Jr., J.M. Chance, and S. Filos Measurement of functional activities in older adults in the community J Gerontol 37 1982 323 329
28. J.L. Cummings The Neuropsychiatric Inventory: assessing psychopathology in dementia patients Neurology 48 Suppl. 1997 S10 S16
29. C.R. Jack Jr., R.C. Petersen, Y.C. Xu, P.C. O'Brien, G.E. Smith, and R.J. Ivnik Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1999 1397 1403
30. Y. Cui, B. Liu, S. Luo, X. Zhen, M. Fan, and T. Liu Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors PloS One 6 2011 e21896
31. R.C. Mohs Administration and scoring manual for the Alzheimer's Disease Assessment Scale, 1994 revised edition 1994 Mount Sinai School of Medicine New York
32. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am J Psychiatry 141 1984 1356 1364
33. A. Rey L'examen clinique en psychologie 1964 Presses Universitaires de France Paris
34. D. Wechsler Wechsler Adult Intelligence Scale - revised 1981 Psychological Corporation New York
35. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hughes, G. van Belle, and G. Fillenbaum The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease Neurology 39 1989 1159 1165
36. H. Goodglass, and E. Kaplan The assessment of aphasia and related disorders 1983 Lea & Febiger Philadelphia
37. R.M. Reitan Validity of the Trail-Making Test as an indicator of organic brain damage Percept Motor Skills 8 1958 271 276
38. E. Kaplan, H. Goodglass, and S. Weintraub The Boston Naming Test 1983 Lea & Febiger Philadelphia
39. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
40. Miao Y, Stijacic Cenzer I, Kirby K, Boscardin WJ. Estimating Harrell's optimism on predictive indices using bootstrap samples. In: Proceedings of the SAS Global Forum, 2013, p. 504. Cary, NC: SAS Institute, Inc.
41. C. Davatzikos, P. Bhatt, L.M. Shaw, K.N. Batmanghelich, and J.Q. Trojanowski Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Neurobiol Aging 32 2011 2322
42. P. Vemuri, H.J. Wiste, S.D. Weigand, L.M. Shaw, J.Q. Trojanowski, and M.W. Weiner MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations Neurology 73 2009 287 293
43. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
44. M. Ewers, C. Walsh, J.Q. Trojanowski, LM Shaw, RC Petersen, and C.R. Jack Jr. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance Neurobiol Aging 33 2012 1203 1214
45. P.T. Trzepacz, P. Yu, J. Sun, K. Schuh, M. Case, and M.M. Witte Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia Neurobiol Aging 35 2014 143 151
46. M.H. Tabert, S.M. Albert, L. Borukhova-Milov, Y. Camacho, G. Pelton, and X. Liu Functional deficits in patients with mild cognitive impairment: prediction of AD Neurology 58 2002 758 764
47. J.J. Gomar, M.T. Bobes-Bascaran, C. Conejero-Goldberg, P. Davies, and T.E. Goldberg Alzheimer's Disease Neuroimaging I. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative Arch Gen Psychiatry 68 2011 961 969
48. D.P. Devanand, X. Liu, P.J. Brown, E.D. Huey, Y. Stern, and G.H. Pelton A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease Int J Alzheimers Dis 2012 2012 483469
49. J. Ye, M. Farnum, E. Yang, R. Verbeeck, V. Lobanov, and N. Raghavan Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data BMC Neurol 12 2012 46
50. V. Jelic, M. Kivipelto, and B. Winblad Clinical trials in mild cognitive impairment: lessons for the future J Neurol Neurosurg Psychiatry 77 2006 429 438